Great update on the current secure trial.
very interesting to see they have now updated the protocol to include an expansion cohort of patients with an enzalutamide combination.
Novartis and Pluvicto just had amazing trial result with this combination
- Forums
- ASX - By Stock
- Ann: Clarity receives US FDA FTD for the treatment of mCRPC
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
4.58%
!
$4.57

Great update on the current secure trial.very interesting to see...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.57 |
Change
0.200(4.58%) |
Mkt cap ! $1.699B |
Open | High | Low | Value | Volume |
$4.37 | $4.64 | $4.36 | $8.180M | 1.805M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 25983 | $4.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.57 | 9622 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 26208 | 4.560 |
7 | 34066 | 4.550 |
10 | 27163 | 4.540 |
5 | 8775 | 4.530 |
8 | 16693 | 4.520 |
Price($) | Vol. | No. |
---|---|---|
4.570 | 6689 | 11 |
4.580 | 3061 | 7 |
4.590 | 21122 | 13 |
4.600 | 141775 | 12 |
4.610 | 12051 | 6 |
Last trade - 11.42am 01/08/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |